Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.88M -21.27M -37.57M -13.45M
Depreciation & Amortization
1.04M 1M 1M 447.41K
Stock-Based Compensation
1.1M 477.5K n/a 1.9M
Other Working Capital
259.42K 432.88K -507.19K -1M
Other Non-Cash Items
2.21M 10.79M 33.25M 4.26M
Deferred Income Tax
n/a n/a n/a 5.34M
Change in Working Capital
-125.26K 1.76M -550.34K -2.98M
Operating Cash Flow
-6.65M -7.24M -3.88M -4.49M
Capital Expenditures
n/a 4.00 n/a -1.75M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a -1.75M
Debt Repayment
1.2M -575K -2.42M -1.62M
Common Stock Repurchased
n/a n/a n/a -247.16K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
500K 200K 4.63M -50.9K
Financial Cash Flow
5.71M 4.92M 5.49M 8.22M
Net Cash Flow
-936.25K -2.32M 1.61M 1.98M
Free Cash Flow
-6.65M -7.24M -3.88M -6.24M